Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Armuzzi

Showing results (251-260 of 320) with videos related to

Pageof 32
Sort By:
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|March 6, 2012
[Predictors of clinical response in patients with ulcerative colitis treated with granulocyte-monocyte apheresis: analysis of the apheresis registry data]Pietro Manuel Ferraro, Valeria D'Ovidio, Giampaolo Bresci, et al.
The Lancet. Gastroenterology & Hepatology|November 21, 2024
Vedolizumab to prevent postoperative recurrence of Crohn's disease (REPREVIO): a multicentre, double-blind, randomised, placebo-controlled trialGeert D'Haens, Carlos Taxonera, Antonio Lopez-Sanroman, et al.
Nutrients|April 13, 2023
Pomegranate Extract Affects Gut Biofilm Forming Bacteria and Promotes Intestinal Mucosal Healing Regulating the Crosstalk between Epithelial Cells and Intestinal FibroblastsGiulia Rizzo, Samuel Elias Pineda Chavez, Elisa Vandenkoornhuyse, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 24, 2022
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel DiseaseLaurent Peyrin-Biroulet, Jean-François Rahier, Julien Kirchgesner, et al.
United European Gastroenterology Journal|October 5, 2024
Defining mucosal healing in randomized controlled trials of inflammatory bowel disease: A systematic review and future perspectiveTommaso Lorenzo Parigi, Virginia Solitano, Alessandro Armuzzi, et al.
Frontiers in Gastroenterology (Lausanne, Switzerland)|March 13, 2026
Innovative, complementary and alternative therapy in inflammatory bowel diseases: A broad 2020s updateLetizia Masi, Cristina Ciuffini, Valentina Petito, et al.
Advances in Therapy|March 9, 2018
Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory DiseaseFernando Rizzello, Ignazio Olivieri, Alessandro Armuzzi, et al.
Journal of Crohn'S & Colitis|September 24, 2016
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical ManagementFernando Gomollón, Axel Dignass, Vito Annese, et al.
Alimentary Pharmacology & Therapeutics|September 19, 2018
The role of multimodal treatment in Crohn's disease patients with perianal fistula: a multicentre retrospective cohort studyShaji Sebastian, Christopher Black, Daniela Pugliese, et al.
Biomedicines|April 23, 2022
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control StudyAlfredo Papa, Franco Scaldaferri, Marcello Covino, et al.
Pageof 32

Showing results (251-260 of 320) with videos related to

Sort By:
Pageof 32
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|March 6, 2012
[Predictors of clinical response in patients with ulcerative colitis treated with granulocyte-monocyte apheresis: analysis of the apheresis registry data]Pietro Manuel Ferraro, Valeria D'Ovidio, Giampaolo Bresci, et al.
The Lancet. Gastroenterology & Hepatology|November 21, 2024
Vedolizumab to prevent postoperative recurrence of Crohn's disease (REPREVIO): a multicentre, double-blind, randomised, placebo-controlled trialGeert D'Haens, Carlos Taxonera, Antonio Lopez-Sanroman, et al.
Nutrients|April 13, 2023
Pomegranate Extract Affects Gut Biofilm Forming Bacteria and Promotes Intestinal Mucosal Healing Regulating the Crosstalk between Epithelial Cells and Intestinal FibroblastsGiulia Rizzo, Samuel Elias Pineda Chavez, Elisa Vandenkoornhuyse, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 24, 2022
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel DiseaseLaurent Peyrin-Biroulet, Jean-François Rahier, Julien Kirchgesner, et al.
United European Gastroenterology Journal|October 5, 2024
Defining mucosal healing in randomized controlled trials of inflammatory bowel disease: A systematic review and future perspectiveTommaso Lorenzo Parigi, Virginia Solitano, Alessandro Armuzzi, et al.
Frontiers in Gastroenterology (Lausanne, Switzerland)|March 13, 2026
Innovative, complementary and alternative therapy in inflammatory bowel diseases: A broad 2020s updateLetizia Masi, Cristina Ciuffini, Valentina Petito, et al.
Advances in Therapy|March 9, 2018
Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory DiseaseFernando Rizzello, Ignazio Olivieri, Alessandro Armuzzi, et al.
Journal of Crohn'S & Colitis|September 24, 2016
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical ManagementFernando Gomollón, Axel Dignass, Vito Annese, et al.
Alimentary Pharmacology & Therapeutics|September 19, 2018
The role of multimodal treatment in Crohn's disease patients with perianal fistula: a multicentre retrospective cohort studyShaji Sebastian, Christopher Black, Daniela Pugliese, et al.
Biomedicines|April 23, 2022
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control StudyAlfredo Papa, Franco Scaldaferri, Marcello Covino, et al.
Pageof 32